Events

Aperçu

Catégorie: Life Sciences

Lieu: Halle 7, Gundeldingerfeld, Dornacherstrasse 192, 4053 Basel

Leonildo  Delgado

Votre interlocuteur

Leonildo Delgado

PhD | Manager Innovation and Sourcing, Therapeutic Innovation and BaseLaunch


Tel. +41 61 295 50 03

leonildo.notexisting@nodomain.comdelgado@baselarea.notexisting@nodomain.comswiss
event Life Sciences

18.09.2019

Investor Spotlight: Ridgeline Therapeutics – A Versant Ventures Discovery Engine

Ridgeline Therapeutics is Versant’s newest discovery engine aimed at translating new opportunities from academics into industry quality therapeutic candidates. Based in Basel, this central European location allows for privileged access to both strong academic research as well as large pharmaceutical partners. Alex Mayweg will provide a deeper look into Ridgeline’s approach on company creation, drug discovery and portfolio successes. Participants will also learn about Ridgeline’s collaborations with academics and pharma companies.
 
When: 18.09.2019, 19:00 - 21:00
Where: Halle 7, Gundeldingerfeld, Dornacherstrasse 192, 4053 Basel
 
Program:

18:30

Door Opening

19:00

Introduction

19:05

Dr. Alex Mayweg, President of Ridgeline Therapeutics, Partner at Versant Ventures

19:35

Q&A

20:00

Networking Apero

 
Participation to the event is free of charge; however, your registration by 16th September 2019 is kindly required.
 

Cookies

Le site BaselArea.swiss utilise des cookies pour améliorer votre navigation. Pour continuer à surfer, veuillez accepter l'utilisation des cookies. 

Ok